Analystreport

Collegium Pharmaceutical Inc (NASDAQ: COLL) was given a new $35.00 price target on by analysts at Cantor Fitzgerald. They now have a "buy" rating on the stock.

Collegium Pharmaceutical, Inc.  (COLL) 
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.collegiumpharma.com